Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Zingiber zerumbet

ABSTRACT: Zingiber zerumbet

PROVIDER: PRJNA1076101 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR27959632_1.fastq.gz	Fastqsanger.gz
	SRR27959632_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Zingiber zerumbet

Project description:Zingiber zerumbet Organism overview

| PRJNA315914 | ENA

Zingiber zerumbet

Project description:Zingiber zerumbet Raw sequence reads

| PRJNA277801 | ENA

Zingiber zerumbet

Project description:Zingiber zerumbet Transcriptome or Gene expression

| PRJNA540419 | ENA

Zingiber zerumbet cultivar:Smith

Project description:Zingiber zerumbet cultivar:Smith Raw sequence reads

| PRJNA277625 | ENA

Zingiber zerumbet cultivar:2010-9

Project description:Zingiber zerumbet cultivar:2010-9 Transcriptome or Gene expression

| PRJNA799465 | ENA

Zingiber zerumbet: A Scoping Review of its Medicinal Properties.

Project description:Zingiber zerumbet, a plant native to tropical and subtropical Asia, has a vast range of traditional uses and has been continuously studied for its medicinal properties. However, a systematic methodological approach in evidence synthesis on the plant's efficacy is lacking, and there is a need to elicit the current research status of this plant. This scoping review was conducted to systematically explore and collate the available scientific evidence on the efficacy of Z. zerumbet and its main phytoconstituents in various formulations, their biological mechanisms, and their safety. Results included 54 articles consisting of animal studies, while there were no published human studies. Only half of the included studies provided adequate reporting on the quality-related details of Z. zerumbet formulations. Identified pharmacological activities were analgesic, anti-inflammatory, anti-diabetic, anti-hyperlipidemic, anti-neoplastic, immunomodulatory, antioxidant, antipyretic, hepatoprotective, nephroprotective, gastroprotective, and locomotor-reducing activities. Notably, the ethanolic extract of Z. zerumbet was found to be well tolerated for up to 28 days. In conclusion, Z. zerumbet and zerumbone have various pharmacological effects, especially in analgesic and anti-inflammatory models. However, there is still a pressing need for comprehensive safety data to conduct clinical trials.

| S-EPMC10869203 | biostudies-literature

Zingiber officinale

Project description:Zingiber officinale overview

| PRJNA135355 | ENA

Zingiber spectabile

Project description:Zingiber spectabile overview

| PRJNA190756 | ENA

Zingiber striolatum

Project description:Zingiber striolatum overview

| PRJNA864980 | ENA

Zingiber mioga

Project description:Zingiber mioga overview